Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Circulation Research|May 26, 2007
RhoGDI-1 modulation of the activity of monomeric RhoGTPase RhoA regulates endothelial barrier function in mouse lungsMatvey Gorovoy, Radu Neamu, Jiaxin Niu, et al.
The Biochemical Journal|May 3, 2002
RGS3 interacts with 14-3-3 via the N-terminal region distinct from the RGS (regulator of G-protein signalling) domainJiaxin Niu, Astrid Scheschonka, Kirk M Druey, et al.
Surgery|October 29, 2024
Neoadjuvant systemic therapy for inoperable differentiated thyroid cancers: Impact on tumor resectabilityKylie Dickerson, Mira Milas, Rosemarie Metzger, et al.
Future Oncology (London, England)|September 4, 2024
The KEYVIBE program: vibostolimab and pembrolizumab for the treatment of advanced malignanciesRonnie Shapira-Frommer, Jiaxin Niu, Ruth Perets, et al.
BMC Public Health|April 11, 2023
Sex differences in impact of cumulative systolic blood pressure from childhood to adulthood on albuminuria in midlife: a 30-year prospective cohort studyDan Wang, Pu-Qing Kou, Yue-Yuan Liao, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 11, 2025
Associations of Genetic Variations in the NR3C2 With Salt Sensitivity, Longitudinal Blood Pressure Changes, and Incidence of Hypertension in Chinese AdultsLan Wang, Ming-Ke Chang, Xue-Mei Yue, et al.
Frontiers in Oncology|June 10, 2026
A phase 1 trial of HPV16 E7 T-cell receptor-engineered T cells in patients with relapsed/refractory HPV16-positive cancers (KITE-439 trial)Kedar Kirtane, Jiaxin Niu, George Blumenschein, et al.
Lung Cancer (Amsterdam, Netherlands)|August 9, 2021
Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancerByoung Chul Cho, Kiyotaka Yoh, Ruth Perets, et al.
JTO Clinical and Research Reports|March 17, 2023
Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade-Resistant Advanced NSCLCMarcelo V Negrao, Vassiliki A Papadimitrakopoulou, Andrew C Price, et al.
Journal of Hypertension|September 9, 2024
Associations of ultra long-term visit-to-visit blood pressure variability, since childhood with vascular aging in midlife: a 30-year prospective cohort studyGuan-Ji Wu, Ai-Ma Si, Yang Wang, et al.
Pageof 7